Dr Reddys Laboratories informs about press release

31 Mar 2016 Evaluate

Dr Reddys Laboratories has informed about a press release dated March 31, 2016, titled ‘Dr. Reddy’s Laboratories Acquires the Rights to Investigational Anticancer Agent E7777 for U.S, Europe and Certain Emerging Markets from Eisai’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1184.30 17.85 (1.53%)
20-Jan-2026 12:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.70
Dr. Reddys Lab 1184.30
Cipla 1378.30
Zydus Lifesciences 875.05
Lupin 2163.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×